Patents by Inventor Elizabeth Thiele

Elizabeth Thiele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEM AND METHOD FOR GRAPHICAL USER INTERFACE WITH FILTER FOR ULTRASOUND IMAGE PRESETS
    Publication number: 20240115240
    Abstract: A graphical user interface displayed by a processing device in operative communication with an ultrasound device may include a preset filter option that provides an easy way to switch between different presets which belong to a preset family. The user uses the preset filter feature to cycle through the different presets in the family while remaining on the same screen that is showing ultrasound images collected in real time. The imaging depth remains the same while the user is using the preset filter feature to select the preset within a family Other settings such as time-gain compensation may not remain the same when cycling between presets. The preset filter feature allows a user to continuously view and assess the ultrasound images being collected in real time while cycling through the presets in the family.
    Type: Application
    Filed: December 20, 2023
    Publication date: April 11, 2024
    Inventors: Murad Omar, Karl Thiele, Abraham Neben, Elizabeth Lauer, Gianfranco Bocchio
  • USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY
    Publication number: 20220323375
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Application
    Filed: June 29, 2022
    Publication date: October 13, 2022
    Inventors: Geoffrey GUY, Stephen WRIGHT, Elizabeth THIELE
  • Use of cannabidiol in the treatment of epilepsy
    Patent number: 11400055
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Grant
    Filed: June 7, 2021
    Date of Patent: August 2, 2022
    Assignee: GW Research Limited
    Inventors: Geoffrey Guy, Stephen Wright, Elizabeth Thiele
  • USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY
    Publication number: 20210290565
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Application
    Filed: June 7, 2021
    Publication date: September 23, 2021
    Inventors: Geoffrey GUY, Stephen Wright, Elizabeth Thiele
  • Use of cannabidiol in the treatment of epilepsy
    Patent number: 11065209
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Grant
    Filed: January 12, 2021
    Date of Patent: July 20, 2021
    Assignee: GW Research Limited
    Inventors: Geoffrey Guy, Stephen Wright, Elizabeth Thiele
  • USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY
    Publication number: 20210145765
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Application
    Filed: January 12, 2021
    Publication date: May 20, 2021
    Inventors: Geoffrey GUY, Stephen WRIGHT, Elizabeth THIELE
  • Use of cannabidiol in the treatment of epilepsy
    Patent number: 10918608
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: February 16, 2021
    Assignee: GW Research Limited
    Inventors: Geoffrey Guy, Stephen Wright, Elizabeth Thiele
  • USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY
    Publication number: 20160166514
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). In particular the TSC is treatment resistant and is characterised by generalised seizures or focal seizures with impairment. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Application
    Filed: October 13, 2015
    Publication date: June 16, 2016
    Inventors: Geoffrey Guy, Stephen Wright, Alice Mead, Elizabeth Thiele